CBER Chagas Serological Lot Release Panel Development Hira L. Nakhasi, Ph.D. Director, Division of Emerging and Transfusion Transmitted Diseases, OBRR/CBER/FDA.
1 Proposed Changes to ICD-9-CM Transfusion Associated Adverse Events September 17th, 2009 ICD-9-CM Coordination and Maintenance Committee Meeting Mikhail.
Standard 7 – Blood and Blood products Philippa Kirkpatrick, Jo Cameron Accrediting Agencies Surveyor Workshop 11 July 2012.
